Cognit AI

🗓 Founded 2022👥 2 employees💰 Last funded Dec 2022
Cognit is crafting a cross-cell, cross-species Large Genomic Model (LGM) that enables high-resolution functional genomics through closed-loop, in-silico, gene expression, and cell engineering, redefining the drug discovery paradigm and precision medicine.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Cognit AI?
Cognit AI has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Cognit AI last raise funding?
The most recent investment in Cognit AI recorded on gritt.io was in December 2022.
When was Cognit AI founded?
Cognit AI was founded in 2022.
What industry is Cognit AI in?
Cognit AI operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.